Gastric Adenocarcinoma — Trials

Gastric Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

447 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 69
Ph III recruiting: 12
Growth YoY: +31.3%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07139951	Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence	enrolling by invitation	Phase 2	16	Mayo ClinicOTHER	1	Jul 1, 2026	clinicaltrials
NCT06862479	Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)(ES-LCCE-UDFM)	enrolling by invitation	—	180	Unidade Local de Saúde Santa MariaOTHER_GOV